Michael Patrick Lowe MD
Cancer Genetics/Cancer Risk Assessment, Gynecologic Cancer
M. Patrick Lowe, M.D., is a founding partner in the Gynecologic Cancer Institute of Chicago. Dr. Lowe is the Director of Gynecologic Oncology and Robotic Surgery Program at Advocate Christ Medical Center. Dr Lowe is an Assistant Professor at the Univ of Illinois at Chicago. Dr Lowe is the former Founder and Director of Robotic Surgery Program at Northwestern Prentice Hospital. www.gcichicago.com
Join to View Full Profile
6700 W 95th StSte 330Oak Lawn, IL 60453
Phone+1 708-422-3242
Fax+1 708-422-3243
Dr. Lowe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Institut Claudius RegaudLaparoscopy, Visiting Fellowship, 2007 - 2007
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gynecologic Oncology, 2002 - 2005
University of Iowa Hospitals and ClinicsResidency, Obstetrics and Gynecology, 1998 - 2002
University of Alabama School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2002 - Present
IL State Medical License 2007 - 2026
FL State Medical License 2012 - 2020
TN State Medical License 2005 - 2009
AR State Medical License 2005 - 2008
IA State Medical License 1998 - 2002
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 3 citationsStabilization of Metastatic Uterine Leiomyosarcoma Using Pembrolizumab.Katherine Cotangco, Mary Meram, M Patrick Lowe
Journal of the National Comprehensive Cancer Network. 2020-08-01 - 25 citationsHuman ovarian tissue cortex surrounding benign and malignant lesions.Mary Ellen Pavone, Jennifer Hirshfeld-Cytron, Candace Tingen, Cristina Thomas, Jessina Thomas
Reproductive Sciences. 2014-05-01 - 40 citationsPhase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal ca...Todd Tillmanns, M. Patrick Lowe, Mark S. Walker, Edward J. Stepanski, Lee S. Schwartzberg
Gynecologic Oncology. 2013-02-01
Press Mentions
Stage IV Melanoma: What Current Role Should Surgery Play?September 10th, 2019
Injecting Genetically Modified Virus into Tumor May Treat Metastatic MelanomaJanuary 31st, 2019
From Pregnancy to Cancer-Free: Christina Welcomes Baby and Survives Skin CancerJuly 5th, 2023
External Links
- GCI Chicagohttp://gcichicago.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
